These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 39365497)
1. Surrogate Immunohistochemical Markers of Proliferation and Embryonic Stem Cells in Distinguishing Ameloblastoma from Ameloblastic Carcinoma. Robinson L; Smit C; van Heerden MB; Moolla H; Afrogheh AH; Opperman JF; Ambele MA; van Heerden WFP Head Neck Pathol; 2024 Oct; 18(1):92. PubMed ID: 39365497 [TBL] [Abstract][Full Text] [Related]
2. Differential Expression of Immunohistochemical Markers in Ameloblastoma & Ameloblastic Carcinoma: A Systematic Review and Meta-analysis of observational studies. Mishra S; Panda S; Mohanty N; Mishra S; Gopinath D; Panda S; Anil S F1000Res; 2024; 13():557. PubMed ID: 39082057 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of SOX2 as a potential marker for ameloblastic carcinoma. Lei Y; Jaradat JM; Owosho A; Adebiyi KE; Lybrand KS; Neville BW; Müller S; Bilodeau EA Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 May; 117(5):608-616.e1. PubMed ID: 24603057 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of K6, K8, K16, K17, K19, maspin, syndecan-1 (CD138), α-SMA, and Ki-67 in ameloblastoma and ameloblastic carcinoma: diagnostic and prognostic correlations. Safadi RA; Quda BF; Hammad HM Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Apr; 121(4):402-11. PubMed ID: 26972539 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical Expression of GLUT-1 and HIF-1α in Tooth Germ, Ameloblastoma, and Ameloblastic Carcinoma. Sánchez-Romero C; Bologna-Molina R; Mosqueda-Taylor A; Paes de Almeida O Int J Surg Pathol; 2016 Aug; 24(5):410-8. PubMed ID: 27020375 [TBL] [Abstract][Full Text] [Related]
6. Embryonic stem cell markers Sox-2 and OCT4 expression and their correlation with WNT signal pathway in cervical squamous cell carcinoma. Ji J; Wei X; Wang Y Int J Clin Exp Pathol; 2014; 7(5):2470-6. PubMed ID: 24966958 [TBL] [Abstract][Full Text] [Related]
7. Comparative histological and immunohistochemical study of ameloblastomas and ameloblastic carcinomas. Martínez-Martínez M; Mosqueda-Taylor A; Carlos-Bregni R; Pires FR; Delgado-Azanero W; Neves-Silva R; Aldape-Barrios B; Paes-de Almeida O Med Oral Patol Oral Cir Bucal; 2017 May; 22(3):e324-e332. PubMed ID: 28390135 [TBL] [Abstract][Full Text] [Related]
8. Association of SOX2, OCT4 and WNT5A Expression in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma: An Immunohistochemical Study. Vijayakumar G; Narwal A; Kamboj M; Sen R Head Neck Pathol; 2020 Sep; 14(3):749-757. PubMed ID: 31902091 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical Expression of MDM2, Bcl-2, SATB2 and Ki-67 in Histological Variants of Unicystic Ameloblastoma. Surana KA; Pandiar D; Krishnan RP Head Neck Pathol; 2024 Oct; 18(1):100. PubMed ID: 39404986 [TBL] [Abstract][Full Text] [Related]
10. Peripheral Ameloblastoma: A Study of 18 Cases and Usage of Ber-EP4 Immunohistochemistry to Rule out a Diagnosis of Intraoral Basal Cell Carcinoma. Upadhyaya JD; Bhattacharyya I; Fitzpatrick SG; Cohen DM; Islam MN J Oral Maxillofac Surg; 2018 May; 76(5):996-1004. PubMed ID: 29247621 [TBL] [Abstract][Full Text] [Related]
11. Expression of the stem cell marker, SOX2, in ameloblastoma and dental epithelium. Juuri E; Isaksson S; Jussila M; Heikinheimo K; Thesleff I Eur J Oral Sci; 2013 Dec; 121(6):509-16. PubMed ID: 24148099 [TBL] [Abstract][Full Text] [Related]
12. Differential expression of glypican-1 in ameloblastoma variants. Bologna-Molina R; Mosqueda-Taylor A; Molina-Frechero N Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):153-60. PubMed ID: 25046223 [TBL] [Abstract][Full Text] [Related]
13. Comparative expression of syndecan-1 and Ki-67 in peripheral and desmoplastic ameloblastomas and ameloblastic carcinoma. Bologna-Molina R; Mosqueda-Taylor A; Lopez-Corella E; de Almeida OP; Carrasco-Daza D; Farfán-Morales JE; Molina-Frechero N; Damián-Matsumura P Pathol Int; 2009 Apr; 59(4):229-33. PubMed ID: 19351365 [TBL] [Abstract][Full Text] [Related]
14. Clinical significance of OCT4 and SOX2 protein expression in cervical cancer. Kim BW; Cho H; Choi CH; Ylaya K; Chung JY; Kim JH; Hewitt SM BMC Cancer; 2015 Dec; 15():1015. PubMed ID: 26706028 [TBL] [Abstract][Full Text] [Related]
15. Report of a Rare Case of Spindle Cell Ameloblastic Carcinoma and the Diagnostic Utility of Immunohistochemistry. Behtaj M; Alawi F; Shanti RM; Cannady S; Zhang PJ; Modi M; Lamzabi I Appl Immunohistochem Mol Morphol; 2021 May-Jun 01; 29(5):394-400. PubMed ID: 33480603 [TBL] [Abstract][Full Text] [Related]
16. Immunoexpression of stem cell markers SOX-2, NANOG AND OCT4 in ameloblastoma. Martins Balbinot K; Almeida Loureiro FJ; Chemelo GP; Alves Mesquita R; Cruz Ramos AMP; Ramos RTJ; da Costa da Silva AL; de Menezes SAF; da Silva Kataoka MS; Alves Junior SM; Viana Pinheiro JJ PeerJ; 2023; 11():e14349. PubMed ID: 36655039 [TBL] [Abstract][Full Text] [Related]
17. Study of Ki67 and CD10 expression as predictive factors of recurrence of ameloblastoma. Ahlem B; Wided A; Amani L; Nadia Z; Amira A; Faten F Eur Ann Otorhinolaryngol Head Neck Dis; 2015 Nov; 132(5):275-9. PubMed ID: 26386615 [TBL] [Abstract][Full Text] [Related]
18. Embryonic stem cells markers SOX2, OCT4 and Nanog expression and their correlations with epithelial-mesenchymal transition in nasopharyngeal carcinoma. Luo W; Li S; Peng B; Ye Y; Deng X; Yao K PLoS One; 2013; 8(2):e56324. PubMed ID: 23424657 [TBL] [Abstract][Full Text] [Related]
19. Expression of RECK and matrix metalloproteinase-2 in ameloblastoma. Zhang B; Zhang J; Xu ZY; Xie HL BMC Cancer; 2009 Dec; 9():427. PubMed ID: 19995435 [TBL] [Abstract][Full Text] [Related]
20. Expression of phosphorylated mTOR and its regulatory protein is related to biological behaviors of ameloblastoma. Li N; Zhong M; Song M Int J Clin Exp Pathol; 2012; 5(7):660-7. PubMed ID: 22977662 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]